Sustainability is more than a commitment, it’s a path to operational efficiency and long-term value creation Read more
Headwinds in remission; revenues of ICRA’s sample set of Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA Read more
PharmaLytica 2024: charting India’s pharma’s path to USD 130 billion by 2030 from the powerhouse hub of Hyderabad Read more